SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-18-001125
Filing Date
2018-02-14
Accepted
2018-02-14 13:10:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 APELLIS PHARMACEUTICALS, INC. p18-0409sc13g.htm SC 13G 47085
  Complete submission text file 0000902664-18-001125.txt   48903
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90187 | Film No.: 18610242
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1 1103
Business Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1 1103 852 2179 1988
Hillhouse Capital Management, Ltd. (Filed by) CIK: 0001510589 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G